FundedIQ
Health Care

Talkiatry: Funding, Investors & Team (Oct 2026)

Talkiatry is a company that provides online psychiatric services within a healthcare network. They have a large team of licensed psychiatrists who offer evaluations, diagnoses, and tailored treatment plans, including medication management when necessary. The company focuses on treating various mental health issues like anxiety, depression, ADHD, and substance use disorders, with the goal of making top-notch psychiatric care easily available and convenient for patients.

www.talkiatry.com LinkedIn New York, United States 251-500 employees
Health Care Medical Mental Health mHealth Wellness B2B B2C
Total raised
$155M
Rounds
3
Latest
Series C
Jun 2024

Talkiatry has raised $155M across 3 funding rounds on record, the most recent a Series C of $130M announced in Jun 2024.

That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.

Talkiatry Company Profile and Key Stats

Total funding raised
$155M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series C
$130M in Jun 2024
Employees
251-500
reported band
Headquarters
New York, United States

Latest funding round on record: Jun 2024.

Talkiatry Funding Rounds

Date
Round
Amount
Series C
$130M
Series A
$20.0M
Series A
$5.0M

Talkiatry raised $5.0M in a Series A announced in Feb 2021.

5 months later, a Series A of $20.0M was announced in Jul 2021.

2.9 years later, a Series C of $130M was announced in Jun 2024.

Talkiatry Founders and Leadership Team

Name
Role
Contact
Robert Krayn
Founder
Locked
Robert K.
CEO
—

Contact details for the Talkiatry team: 1 of 2 have an email address on file.

Start 14-day free trial →

Talkiatry Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,659
$4.9M
30,234
$7.6M
1,869
$60M

Talkiatry's latest round of $130M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Talkiatry in Health Care and New York

Companies Similar to Talkiatry

Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…

Series A $25.0M

PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…

Undisclosed round $3.7M

General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…

Series B $120M

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…

Series D $52.0M

SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…

Undisclosed round $4.0M

Aptatek is developing cutting edge technologies for portable disease management devices that will improve…

Undisclosed round —

Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…

Undisclosed round $150k

Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…

Undisclosed round $1.0M

For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…

Seed $250k

Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…

Undisclosed round $14.5M

Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…

Series B $14.9M

People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…

Undisclosed round $47.0M

Talkiatry Funding FAQs

What does Talkiatry do?

Talkiatry is a company that provides online psychiatric services within a healthcare network. They have a large team of licensed psychiatrists who offer evaluations, diagnoses, and tailored treatment plans, including medication management when necessary. The company focuses on treating various mental health issues like anxiety, depression, ADHD, and substance use disorders, with the goal of making top-notch psychiatric care easily available and convenient for patients.

How much funding has Talkiatry raised?

Talkiatry has raised $155M across 3 rounds on record. The most recent is a Series C of $130M announced in Jun 2024.

When did Talkiatry last raise funding?

Talkiatry's most recent funding round on record is a Series C of $130M, announced in Jun 2024.

Who founded Talkiatry?

FundedIQ lists Robert Krayn (Founder) at Talkiatry.

Who is the CEO of Talkiatry?

Robert K. is listed as CEO at Talkiatry.

Where is Talkiatry headquartered?

Talkiatry is based in New York, United States.

How many employees does Talkiatry have?

Talkiatry is in the 251-500 employee band.

How does Talkiatry's funding compare to other Health Care startups?

Talkiatry's latest round of $130M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.

About FundedIQ's Talkiatry Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Talkiatry is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.